Article Information
vol. 8 no. 2
Published By
Online ISSN
History
- Received December 28, 2021
- Accepted February 11, 2022
- Published online April 11, 2022.
Article Versions
- previous version (February 24, 2022 - 07:32).
- You are viewing the most recent version of this article.
Copyright & Usage
The content of this work is not subject to copyright. Design and branding are copyright ©ERS 2022. This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- 1Epidemiology and Population Studies Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, USA
- 2Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA
- Corresponding author: Emily E. Ricotta (emily.ricotta{at}nih.gov)
Funding
National Heart, Lung, and Blood Institute
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Article usage
Altmetrics
Vol 8 Issue 2
Table of Contents
CFTR modulator use and risk of nontuberculous mycobacteria positivity in cystic fibrosis, 2011–2018
